HIV/AIDS Austerity: How 2026 Federal and State Cuts Endanger 30 Years of Progress

Introduction: The Convergence of Ideology and Austerity

In January 2026, the trajectory of the HIV/AIDS epidemic in the United States shifted violently. For decades, the national strategy relied on a bipartisan consensus that prioritized viral suppression through robust federal funding and state-level cooperation. That consensus has fractured. A simultaneous contraction of federal support, delineated in the Trump administration's Fiscal Year 2026 budget, and a drastic restructuring of safety nets in Florida under Governor Ron DeSantis, has created a "perfect storm" that threatens to undo thirty years of public health progress.¹

This report offers a deep-dive analysis of these policy shifts. It examines the transformation of the Department of Health and Human Services (HHS) into the "Administration for a Healthy America" (AHA), the dismantling of the Centers for Disease Control and Prevention’s (CDC) prevention infrastructure, and the abrupt eligibility contractions in Florida’s AIDS Drug Assistance Program (ADAP). By synthesizing policy analysis with epidemiological projections and biological realities, this article illustrates how fiscal retrenchment is poised to reverse viral suppression rates, accelerate the emergence of drug-resistant viral strains, and widen health disparities among vulnerable populations in the American South.

Part I: The Federal Landscape and the FY 2026 Budget for HIV/AIDS

The federal approach to HIV/AIDS management is undergoing its most significant structural transformation since the enactment of the Ryan White CARE Act in 1990. The proposed FY 2026 budget signals a philosophical and logistical departure from the "Ending the HIV Epidemic" (EHE) framework, favoring a consolidation strategy that dilutes specialized care into generalized block grants.

The Rise of the Administration for a Healthy America (AHA)

At the heart of the federal restructuring is the creation of the Administration for a Healthy America (AHA). This new agency is designed to consolidate functions previously distributed across the Health Resources and Services Administration (HRSA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the CDC.²

The rationale provided by the administration is one of efficiency and a return to "gold standard science" aimed at ending the country's chronic illness epidemic.⁴ However, the operational reality involves moving the Ryan White HIV/AIDS Program—the federal safety net providing care to over half a million low-income people with HIV—out of HRSA and into the AHA.²

This transfer is not merely administrative; it represents a de-prioritization of infectious disease specialization. HRSA has historically managed the Ryan White program with a specific focus on the unique, wrap-around needs of people living with HIV (PLWH), including dental care, case management, and mental health services. The AHA, with its broad mandate to address everything from maternal health to environmental risks, lacks this specialized focus. Critics argue that placing HIV care within a massive, generalized bureaucracy will lead to the "invisibilization" of the epidemic, where HIV becomes just another chronic condition competing for resources within a capped budget.³

Furthermore, the budget eliminates Part F of the Ryan White Program.⁷ Part F historically funded the AIDS Education and Training Centers (AETCs), the Special Projects of National Significance (SPNS), and dental programs. The elimination of AETCs is particularly damaging, as these centers train the next generation of HIV clinicians. Without them, the workforce pipeline—already strained by burnout and retirements—faces collapse, just as the complexity of HIV care increases with an aging patient population.²

Dismantling the CDC’s Prevention Infrastructure

If the changes to care are structural, the changes to prevention are existential. The FY 2026 budget proposes the elimination of separate funding streams for HIV prevention, sexually transmitted infections (STIs), viral hepatitis, and tuberculosis at the CDC.⁸ In their place, the administration proposes a single "Infectious Disease Block Grant" funded at $300 million.¹⁰

To contextualize the severity of this cut: in previous fiscal years, the aggregate funding for these individual programs exceeded $1 billion. The proposal effectively slashes federal investment in disease prevention by over 70%.⁵ This block grant model ends the federal mandate for HIV surveillance and prevention, transferring decision-making power and a significantly reduced pot of money to state authorities.⁹

The consequences of this shift are profound. The CDC’s prevention funding supports the backbone of the nation's epidemiological intelligence: surveillance systems that track outbreaks, partner notification services that break chains of transmission, and the implementation of Pre-Exposure Prophylaxis (PrEP) programs. By zeroing out the CDC’s HIV prevention account, the federal government is effectively blinding itself to the movement of the virus.⁹ In states with political leadership hostile to specific prevention modalities—such as needle exchange programs or sex-positive education—this structure allows for the complete defunding of evidence-based interventions without federal oversight.

The Ideological Dimension: "Make America Healthy Again" and Project 2025

The policy shifts are not occurring in a vacuum; they are driven by a specific ideological framework. The budget explicitly aligns with the "Make America Healthy Again" (MAHA) initiative and the principles outlined in Project 2025, a conservative mandate developed by The Heritage Foundation.⁴

Project 2025 emphasizes the deconstruction of the "administrative state" and the elimination of programs viewed as promoting "woke" ideology. In the context of HIV, this manifests in the targeting of the Minority AIDS Initiative (MAI). The FY 2026 budget proposes the elimination of the MAI, which was established to address the disproportionate impact of HIV on racial and ethnic minorities.⁷ The administration argues that such programs are divisive "DEI" (Diversity, Equity, and Inclusion) initiatives. However, epidemiological data confirms that Black and Latino communities bear the heaviest burden of the epidemic. Removing targeted funding for these groups is not a "race-neutral" policy; it is a policy that willfully ignores the unequal topography of the disease.⁴

Additionally, the budget emphasizes "family values" and redirects funding away from organizations that provide comprehensive reproductive health services, further entangling HIV prevention with the contentious politics of abortion and contraception.¹² This ideological filtering of public health funding threatens to sever partnerships with trusted community-based organizations that have spent decades building rapport with marginalized populations.

Part II: The Florida Crisis – A Case Study in Collapse

While federal changes loom as proposed legislation, the state of Florida has already enacted sweeping cuts that serve as a real-time case study of the impact of retrenchment. In January 2026, the Florida Department of Health (FDOH) announced drastic changes to the state’s AIDS Drug Assistance Program (ADAP), creating a crisis that advocates describe as unprecedented.¹³

The Eligibility Cliff: From Safety Net to Tightrope

Effective March 1, 2026, Florida ADAP will reduce its income eligibility threshold for uninsured clients from 400% of the Federal Poverty Level (FPL) to 130% FPL.¹³

To understand the magnitude of this change, one must look at the demographics of the epidemic in Florida. The state has consistently ranked among the highest in the nation for new HIV diagnoses.¹⁵ Many Floridians living with HIV are the "working poor"—individuals who work in the service industry, tourism, or gig economy. They earn too much to qualify for Medicaid (which Florida has refused to expand) but often too little to afford comprehensive private insurance with high deductibles.

Under the previous 400% FPL threshold (approximately $62,600 for an individual in 2025), these workers could access life-saving medications through ADAP. Under the new 130% threshold (approximately $20,345), they are abandoned.¹³ The National Alliance of State and Territorial AIDS Directors (NASTAD) estimates that roughly 50% of Florida’s 32,000 ADAP clients fall into this income gap.¹⁴

This creates a massive "eligibility cliff." Approximately 16,000 Floridians are projected to lose access to direct medication provision overnight.¹⁶ The FDOH argues that these individuals should transition to federally subsidized insurance plans under the Affordable Care Act (ACA). However, the timing of the announcement—mid-January, with changes effective March 1—gave clients less than two months to navigate a complex insurance market, often after open enrollment periods had closed or were closing.¹⁷ For a person living with HIV, a gap in coverage of even a few weeks can be catastrophic.

Formulary Restrictions: The Loss of Biktarvy

Compounding the eligibility cuts, the FDOH has altered the ADAP formulary, prioritizing cost over clinical best practices. The state announced the removal of Biktarvy—the most widely prescribed, single-tablet regimen for HIV treatment—from the ADAP formulary.¹⁴

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is a gold-standard medication because of its high barrier to genetic resistance, minimal side effects, and lack of dietary restrictions. It is a "forgiving" drug, ideal for patients who may struggle with perfect adherence. By removing it, the state is forcing stable patients to switch to older, potentially multi-tablet regimens or those with more side effects.

This "non-medical switching" introduces significant risks. Patients forced to change medications often experience anxiety, confusion, and new side effects, all of which can lead to poor adherence. Furthermore, the FDOH has restricted Descovy (used for PrEP and treatment) to only those with specific renal insufficiencies, further limiting clinician autonomy.¹⁴ The International Association of Providers of AIDS Care (IAPAC) has condemned these moves, noting that cost stewardship should never override clinical judgment or jeopardize viral suppression.¹⁴

The False Economy of "Sustainability"

The FDOH justifies these cuts by citing a projected $120 million shortfall and the need for "financial sustainability".¹⁹ However, critics point out that the shortfall is largely a manufactured crisis.

First, the state has systematically rejected federal funding that could have alleviated budget pressures. Under Governor Rick Scott, Florida returned $54 million in unspent federal HIV grants and blocked counties from applying for $16 million in CDC prevention funds.²⁰ This pattern of refusing federal aid for ideological reasons laid the groundwork for the current deficit.

Second, the structural changes to ADAP actually destroy its revenue model. ADAP programs typically purchase drugs at reduced rates and receive rebates from pharmaceutical manufacturers. These rebates are then reinvested into the program to fund services. By eliminating the rebate model and premium assistance, Florida is cutting off the very revenue stream that kept the program solvent.¹⁶ The "savings" achieved by cutting 16,000 people from care will likely be dwarfed by the long-term costs of treating the resulting new infections and AIDS-related hospitalizations, costs that will ultimately fall on the state’s public hospital system.¹⁷

Part III: The Human Impact – Communities on the Brink

The abstract numbers of budgets and poverty levels translate into visceral fear and desperation on the ground. Community-based organizations (CBOs) across Florida are scrambling to fill the void left by the state's retreat.

The Poverello Center: Food as Medicine

In Wilton Manors, the Poverello Center, a specialized food pantry for people living with HIV, is witnessing the ripple effects of the crisis. When patients are forced to pay out-of-pocket for medical care or insurance premiums, their food budget is often the first thing to be sacrificed. Poverello has reported a surge in demand, necessitating the expansion of services to include the dependents of PLWH for the first time.²²

The center, led by CEO Tom Pietrogallo, emphasizes that food security is HIV care. Antiretroviral medications must often be taken with food to be effective, and malnutrition weakens the immune system, making PLWH more susceptible to opportunistic infections. The Poverello Center’s struggle highlights the intersectionality of the crisis: the ADAP cuts don't just take away pills; they destabilize the entire hierarchy of needs for vulnerable families.²²

Latinos Salud and The Pride Center: Frontline Defenses

Organizations like Latinos Salud in Miami and The Pride Center at Equality Park in Fort Lauderdale are facing a dual threat. They are seeing an influx of terrified clients seeking navigation services to find new insurance or medication sources. Simultaneously, their own funding is imperiled by the federal shifts. These organizations rely on federal pass-through grants (often Part A and Part F of Ryan White) to fund their testing, outreach, and linkage-to-care programs.²⁴

If the federal AHA reorganization disrupts the flow of these grants, or if the "anti-woke" provisions in the budget disqualify LGBTQ-focused agencies, the community infrastructure will collapse. Latinos Salud, specifically focused on the gay Latino community, provides culturally competent care that a generalized state health department cannot replicate. The loss of their capacity would be devastating in Miami-Dade County, which already has one of the highest HIV prevalence rates in the nation.²⁶

The Response: Advocacy and Resistance

The community has not remained silent. On January 20, 2026, the AIDS Healthcare Foundation (AHF) organized a "Fight For Our Lives" rally at the historic state capitol building in Tallahassee.¹⁸ Over 100 advocates and healthcare providers gathered to demand the reversal of the ADAP cuts.

Advocates like Michael Emanuel Rajner and organizations including Equality Florida have been mobilizing to meet with lawmakers, testifying that these cuts are a "death sentence" for thousands.²⁹ The rally highlighted the disconnect between the state's administrative decisions and the clinical reality. Speakers emphasized that the "administrative issues" cited by the FDOH are solving a budget math problem with human lives.¹⁸

Part IV: The Science of Collapse – Epidemiological Consequences

To fully understand the danger of these policy shifts, one must examine the biological mechanisms of HIV. The virus is relentless and biological processes do not negotiate with budget cycles. The interruption of treatment for 16,000 Floridians and potentially hundreds of thousands of Americans nationally will trigger a predictable and disastrous chain of biological events.

Viral Rebound Kinetics: The Speed of Recrudescence

Modern HIV treatment suppresses the virus to "undetectable" levels, meaning it cannot be found in the blood using standard tests. However, the virus remains hidden in the body in a "latent reservoir"—a collection of resting memory CD4+ T-cells that contain the genetic code of the virus.³⁰

Antiretroviral therapy (ART) acts as a constant suppressor, keeping this reservoir dormant. When a patient stops taking medication—whether because they were kicked off ADAP or because their clinic closed—the suppression lifts. This is known as Analytical Treatment Interruption (ATI) in clinical trials, but in the real world, it is simply "treatment failure."

The kinetics of this rebound are terrifyingly fast. Studies show that plasma viral load typically rebounds to detectable levels (>50 copies/mL) within two to four weeks of stopping medication.³¹ Within days of becoming detectable, the viral load can spike exponentially, returning to pre-treatment levels. This phenomenon, known as recrudescence, means that a person who was healthy and non-infectious in February could be highly infectious and falling ill by April.

The Genesis of Drug Resistance: The Mutation Factory

Perhaps the most insidious consequence of the Florida formulary changes and federal disruptions is the incubation of drug resistance. HIV is a highly mutable virus; it makes mistakes when it copies itself. Some of these mistakes (mutations) allow it to evade the drugs designed to kill it.

Drug resistance typically emerges when the virus replicates in the presence of sub-optimal levels of medication. This is exactly the scenario created by the current policies.

1. Forced Switching: When patients are forced to switch from a single-tablet regimen like Biktarvy to a multi-pill regimen, adherence often drops. Missing doses creates a window where drug levels in the blood are too low to stop replication but high enough to select for resistant mutants.

2. Treatment Interruption: When a patient stops a regimen, the drugs don't leave the body instantly. They have different "half-lives." If a patient stops a cocktail where one drug lingers in the body longer than the others, the virus effectively encounters "monotherapy" (treatment with only one drug). This is the perfect environment for resistance to develop.

A study of patients undergoing treatment interruptions found a drug resistance prevalence of 19.6% among those who experienced unplanned breaks in care.³³ Specific mutations, such as K103N (which confers resistance to non-nucleoside reverse transcriptase inhibitors), can become permanently archived in the patient's viral reservoir.³³ Once a patient develops resistance, their treatment becomes much harder, much more expensive, and much less effective. They can also transmit this resistant virus to others, spreading a strain of HIV that is already immune to first-line treatments.

Transmission Models: The Ripple Effect

The concept of "Undetectable = Untransmittable" (U=U) is the cornerstone of modern HIV prevention. It states that a person with a suppressed viral load cannot sexually transmit HIV.³⁴ The policy of removing people from treatment directly undermines U=U.

When 16,000 people in Florida lose access to medication, they do not just get sick; they become potential vectors for transmission. This leads to a rise in "community viral load"—the aggregate amount of virus circulating in a specific population.

Mathematical modeling paints a grim picture of this future.

• Johns Hopkins Medicine Model: Researchers predict that ending federal funding for the Ryan White program could result in a 49% increase in new HIV infections across 31 U.S. cities by 2030.³⁵

• The Lancet HIV Study: A separate study estimates that disruptions to funding and services could lead to 75,436 additional infections nationally by 2030.³⁶

• Tennessee Case Study: In Tennessee, where the state rejected $8 million in CDC prevention funding in favor of state-managed programs, models by Yale and Massachusetts General Hospital projected that the reallocation would result in 190 additional deaths and 166 additional HIV transmissions over a decade.³⁷

These models confirm that "saving money" on HIV care is a mathematical fallacy. The lifetime cost of treating a single HIV infection is estimated to be over $500,000. The 166 additional infections predicted in Tennessee alone represent over $80 million in future medical costs—far exceeding the $8 million "saved" by rejecting the grant. Florida's potential 16,000 disenrolled patients represent a catastrophic future liability of billions of dollars.

Part V: Comparative and Global Contexts

The Tennessee Warning

Florida is not the first state to walk this path. Tennessee serves as the "canary in the coal mine." In 2024 and 2025, Tennessee rejected CDC funding that supported CBOs like A Betor Way in Memphis and Nashville CARES.³⁹ The state replaced this funding with a smaller pot of state money directed toward "first responders" and "victims of human trafficking," explicitly ignoring the populations most at risk: MSM and transgender women.

The result was the collapse of the HIV prevention infrastructure in Memphis. CBOs lost 45% of their prevention dollars, forcing the closure of clinics and the cessation of testing services.⁴⁰ This shift away from "CDC priority populations" to "state priority populations" is the exact mechanism proposed in the federal FY 2026 block grant model. Florida is essentially scaling up the Tennessee disaster to a state with a population three times larger and an epidemic ten times more severe.

Global Implications: Retreating from the World

The U.S. retreat from HIV leadership is not limited to domestic policy. The FY 2026 budget also signals a pullback from global commitments. The President's Emergency Plan for AIDS Relief (PEPFAR), responsible for saving over 25 million lives globally, faces a "short-term authorization" and increasing scrutiny.⁴¹

The budget proposes the reinstatement of the "Mexico City Policy", which blocks U.S. global health funding to foreign NGOs that perform or promote abortion as a method of family planning.¹² This policy, often called the "Global Gag Rule," historically fragments health delivery systems in developing nations, as many clinics that provide HIV care also provide reproductive health services.

Furthermore, the "America First" approach to aid has led to the freezing of USAID contracts and the dismissal of staff, disrupting supply chains for antiretrovirals in sub-Saharan Africa. Models suggest that if international support declines, we could see an additional 10.75 million new HIV infections globally by 2030.⁴² The U.S. is not just dismantling its own safety net; it is pulling the plug on the global life support system for HIV/AIDS.

Conclusion: The Choice Before Us

As 2026 unfolds, the United States stands at a precipice. The convergence of the Trump administration’s FY 2026 budget and Governor DeSantis’s ADAP restructuring represents a systematic dismantling of the HIV/AIDS safety net. These are not merely fiscal adjustments; they are ideological choices that prioritize short-term austerity and political posturing over established public health science.

The data is unequivocal. Replacing categorical, disease-specific funding with block grants destroys the specialized infrastructure necessary to fight a complex virus. Reducing income eligibility for state assistance forces the working poor out of care. Removing effective drugs from formularies breeds resistance.

The consequences will be measured in rising viral loads, resistant strains that render our best medicines useless, and a resurgence of deaths from a disease that was once considered manageable. The displacement of 16,000 Floridians from care is not an administrative statistic; it is a mass casualty event in slow motion.

As advocates rally in Tallahassee and Washington, they are fighting for more than just a budget line item. They are fighting for the survival of a public health model that values human life over political ideology. The infrastructure of care, built painstakingly over forty years by activists, scientists, and survivors, is proving fragile. Its survival now depends on whether policymakers can be convinced to look at the viral kinetics, the transmission models, and the human faces of the epidemic, rather than the bottom line of a ledger.

Table 1: Comparative Analysis of Funding Structures (FY2025 vs. FY2026 Proposal)

Program / Initiative	FY 2025 Structure (Baseline)	FY 2026 Proposed Structure (Trump/AHA)	Impact Analysis
Ryan White Program	Housed in HRSA; categorical grants (Parts A, B, C, D, F).	Moved to Administration for a Healthy America (AHA); Part F eliminated.	Dilution of HIV-specific focus; loss of dental (Part F) and training programs (AETCs).
CDC Prevention	Dedicated lines for HIV, STI, Hep, TB ($1.013B HIV).	Consolidated Infectious Disease Block Grant ($300M total).	~70% reduction in dedicated funding; loss of federal surveillance mandate; shift to state control.
Ending the HIV Epidemic (EHE)	$573M across agencies (CDC, HRSA, NIH).	Transferred to AHA; funding flat ($220M) or eliminated in House bills.	Severed from CDC data systems; potential dissolution of targeted jurisdictional approach.
Minority AIDS Initiative (MAI)	$60M dedicated fund (Secretary's Fund).	Eliminated.	Disproportionate harm to Black/Latino communities; loss of equity-focused interventions.
Florida ADAP Eligibility	400% Federal Poverty Level (FPL).	130% Federal Poverty Level (FPL).	Disenrollment of ~16,000 clients; rise in unsuppressed viral loads; loss of "working poor" coverage.
Florida ADAP Formulary	Included Biktarvy (Single Tablet Regimen).	Biktarvy Removed; Descovy restricted.	Forced regimen switching; increased pill burden; higher risk of non-adherence and drug resistance.

Table 2: Projected Health Outcomes of Funding Cessation

Metric	Projection	Source Model
New Infections (National)	+49% by 2030 if Ryan White is defunded.	Johns Hopkins Medicine Model 35
Excess Infections (National)	75,436 additional cases by 2030.	The Lancet HIV / Burnet Institute 36
Economic Impact (Tennessee Case)	Reallocation leads to 190 additional deaths and 166 transmissions over 10 years.	Clinical Infectious Diseases (Yale/MGH) 37
Viral Rebound Rate	Detectable viral load within 2-4 weeks of interruption.	PLOS Computational Biology 32
Drug Resistance Prevalence	19.6% prevalence of resistance mutations after unplanned interruption.	Frontiers in Microbiology 33
Global Impact	10.75 million new infections by 2030 if global funding declines.	The Lancet HIV / WHO 42

Works cited

1. SAVE HIV FUNDING CAMPAIGN SOUNDS ALARM ON PERFECT STORM EMERGING FOR HIV CARE WITH STATE AND FEDERAL CUTS COLLIDING ACROSS THE COUNTRY, RELEASES RAPID RESPONSE MEDIA RESOURCE KIT AND STATEMENTS, accessed January 20, 2026, https://savehivfunding.org/save-hiv-funding-campaign-sounds-alarm-on-perfect-storm-emerging-for-hiv-care-with-state-and-federal-cuts-colliding-across-the-country-releases-rapid-response-media-resource-kit-and-statements/

2. Scaling Back the Nation's HIV Response? What the Trump Administration's HHS Budget May Do| KFF Quick Takes, accessed January 20, 2026, https://www.kff.org/quick-take/scaling-back-the-nations-hiv-response-what-the-trump-administrations-hhs-budget-may-do/

3. White House Budget Focuses on MAHA Agenda - Applied Policy, accessed January 20, 2026, https://www.appliedpolicy.com/white-house-budget-for-2026-has-maha-focus/

4. Fiscal Year 2026 Budget in Brief - HHS.gov, accessed January 20, 2026, https://www.hhs.gov/sites/default/files/fy-2026-budget-in-brief.pdf

5. White House Releases Additional Details for the Fiscal Year 2026 President's Budget Request - NACCHO, accessed January 20, 2026, https://www.naccho.org/blog/articles/white-house-releases-additional-details-for-the-fiscal-year-2026-presidents-budget-request

6. Administration Proposes FY 2026 HHS Budget - America's Essential Hospitals, accessed January 20, 2026, https://essentialhospitals.org/administration-proposes-fy-2026-hhs-budget/

7. Tell Congress: No HIV Funding Cuts - AIDS United, accessed January 20, 2026, https://aidsunited.org/tell-congress-no-hiv-funding-cuts/

8. On the House's Proposed FY 2026 Spending Bill - National Coalition for LGBTQ Health, accessed January 20, 2026, https://healthlgbtq.org/advocacy_brief/on-the-houses-proposed-fy-2026-spending-bill/

9. Trump Budget Ends All CDC HIV Prevention Programs, While Maintaining Care, Treatment, and PrEP, accessed January 20, 2026, https://hivhep.org/press-releases/trump-budget-ends-all-cdc-hiv-prevention-programs-while-maintaining-care-treatment-and-prep/

10. Domestic HIV Funding in the White House FY2026 Budget Request - KFF, accessed January 20, 2026, https://www.kff.org/hiv-aids/domestic-hiv-funding-in-the-white-house-fy2026-budget-request/

11. Policy Resource: Understanding and Assessing Project 2025 - AIDS United, accessed January 20, 2026, https://aidsunited.org/project2025-resource/

12. Fiscal-Year-2026-Discretionary-Budget-Request.pdf - The White House, accessed January 20, 2026, https://www.whitehouse.gov/wp-content/uploads/2025/05/Fiscal-Year-2026-Discretionary-Budget-Request.pdf

13. DNC slams White House for slashing Fla. AIDS funding, accessed January 20, 2026, https://www.washingtonblade.com/2026/01/16/dnc-slams-white-house-for-slashing-fla-aids-funding/

14. News Alert – Florida ADAP Changes - International Association of Providers of AIDS Care, accessed January 20, 2026, https://www.iapac.org/2026/01/12/news-alert-florida-adap-changes/

15. Integrated HIV - Prevention and Care Plan - Florida Department of Health, accessed January 20, 2026, https://www.floridahealth.gov/wp-content/uploads/2025/06/florida-ipc-2022-26.pdf

16. Florida ADAP Crisis + State Cuts Rapid Response Kit - Save HIV Funding, accessed January 20, 2026, https://savehivfunding.org/florida-adap-crisis-state-cuts-rapid-response-kit/

17. AIDS United Condemns DeSantis Administration For Putting Tens of Thousands of Lives At Risk By Gutting Florida ADAP, accessed January 20, 2026, https://aidsunited.org/aids-united-condemns-desantis-administration-for-putting-tens-of-thousands-of-lives-at-risk-by-gutting-florida-adap/

18. Healthcare Advocates Join AHF to Question Florida Officials Eliminating Access to Care When HIV Rates Are on the Rise | Morningstar, accessed January 20, 2026, https://www.morningstar.com/news/business-wire/20260120022488/healthcare-advocates-join-ahf-to-question-florida-officials-eliminating-access-to-care-when-hiv-rates-are-on-the-rise

19. AIDS Drug Assistance Program - Florida Department of Health, accessed January 20, 2026, https://www.floridahealth.gov/individual-family-health/injury-prevention-wellness/hiv-aids/hiv-aids-management/

20. FL GOV. DESANTIS PUSHING FOR A 'ROBUST PROGRAM' TO REDUCE HIV AND AIDS, accessed January 20, 2026, https://knowyourhivstatus.com/fl-gov-desantis-pushing-for-a-robust-program-to-reduce-hiv-and-aids/

21. 'Rick Scott Fueled The Epidemic': How FL Said No To $70M In HIV Prevention | WLRN, accessed January 20, 2026, https://www.wlrn.org/show/sundial/2019-09-17/rick-scott-fueled-the-epidemic-how-fl-said-no-to-70m-in-hiv-prevention

22. NEW FUNDING: PUBLIX SUPERMARKETS CHARITIES HELPS POVERELLO FEED DEPENDENTS OF PEOPLE WITH HIV FOR THE FIRST TIME, accessed January 20, 2026, https://poverello.org/tag/lack-of-food-security-impact/

23. Poverello Center, Inc. Awarded $40000 Grant from The Our Fund Foundation's Pillars Fund, accessed January 20, 2026, https://poverello.org/tag/eatwellsfl/

24. Community Newsletter | AidsNet - Miami-Dade HIV/AIDS Partnership, accessed January 20, 2026, https://aidsnet.org/news-and-resources/

25. Party with A Purpose as Florida AIDS Walk Celebrates 20 Years - OCQ - OutClique, accessed January 20, 2026, https://www.outclique.com/party-with-a-purpose-as-florida-aids-walk-celebrates-20-years/

26. MEMORANDUM - Miami-Dade County, accessed January 20, 2026, https://www.miamidade.gov/govaction/legistarfiles/Matters/Y2024/242110.pdf

27. Progress and Challenges in “Getting to Zero” New HIV Infections in Miami, Florida - PMC, accessed January 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC6573019/

28. Healthcare Advocates Join AHF to Question Florida Officials Eliminating Access to Care When HIV Rates Are on the Rise - Business Wire, accessed January 20, 2026, https://www.businesswire.com/news/home/20260120022488/en/Healthcare-Advocates-Join-AHF-to-Question-Florida-Officials-Eliminating-Access-to-Care-When-HIV-Rates-Are-on-the-Rise

29. Resistance Report Week 1: Lives Are At Risk — Help Us Fight Back | Equality Florida, accessed January 20, 2026, https://www.eqfl.org/2026-Resistance-Report-Week1

30. Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of Infection - NIH, accessed January 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC6941494/

31. Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral Therapy - PMC - NIH, accessed January 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC7751567/

32. Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers | PLOS Computational Biology, accessed January 20, 2026, https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1007229

33. HIV drug resistance and its associated factors among patients during interruption of antiretroviral therapy in China - Frontiers, accessed January 20, 2026, https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1617795/full

34. The HIV/AIDS Epidemic in the United States: The Basics | KFF, accessed January 20, 2026, https://files.kff.org/attachment/Fact-Sheet-HIV-AIDS-in-the-United-States-The-Basics

35. Ending Federally Funded Ryan White HIV/Aids Program Would Increase New HIV Infections 49% Nationwide by 2030, Computer Model Predicts, accessed January 20, 2026, https://www.hopkinsmedicine.org/news/newsroom/news-releases/2025/09/ending-federally-funded-ryan-white-hivaids-program-would-increase-new-hiv-infections-49-nationwide-by-2030-computer-model-predicts

36. Funding cuts to US HIV preventive services could lead to thousands more cases, billions in costs | CIDRAP, accessed January 20, 2026, https://www.cidrap.umn.edu/hivaids/funding-cuts-us-hiv-preventive-services-could-lead-thousands-more-cases-billions-costs

37. Projecting the Potential Clinical and Economic Impact of HIV Prevention Resource Reallocation in Tennessee - Oxford Academic, accessed January 20, 2026, https://academic.oup.com/cid/article/79/6/1458/7697991

38. Study Finds That Tennessee's Shift in HIV Prevention Funding Will Lead to Poorer Health Outcomes for its Residents, accessed January 20, 2026, https://www.massgeneral.org/news/press-release/tennessee-shift-in-hiv-policy-will-lead-to-poorer-outcomes

39. Loss of $4M Grant Threatens HIV Prevention Efforts In Tennessee, accessed January 20, 2026, https://www.psrmemphis.org/loss-of-4m-grant-threatens-hiv-prevention-efforts-in-tennessee/

40. Nashville CARES Hit by Tumultuous Year for HIV/AIDS Funding | City Limits, accessed January 20, 2026, https://www.nashvillescene.com/news/citylimits/nashville-cares-hiv-aids-funding/article_d81f942c-539a-574e-90da-6764f4de7649.html

41. The Outlook for PEPFAR in 2025 and Beyond - KFF, accessed January 20, 2026, https://www.kff.org/global-health-policy/the-outlook-for-pepfar-in-2025-and-beyond/

42. New study highlights the potential impact of funding cuts on the HIV response, accessed January 20, 2026, https://www.who.int/news/item/26-03-2025-new-study-highlights-the-potential-impact-of-funding-cuts-on-the-hiv-response